The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $88.18

Today's change+0.44 +0.50%
Updated September 4 10:24 AM EDT. Delayed by at least 15 minutes.
 

Medivation Inc

Nasdaq: MDVN
Last

(U.S.) $88.18

Today's change+0.44 +0.50%
Updated September 4 10:24 AM EDT. Delayed by at least 15 minutes.

Medivation Inc up (U.S.)$0.44

Medivation Inc is up today by (U.S.)$0.44 or 0.50% to (U.S.)$88.18. Over the last five days, shares have lost 4.58% and are down 11.47% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $86.78
  • Previous close(U.S.) $87.74
  • High(U.S.) $88.27
  • Low(U.S.) $86.39
  • Bid / Ask(U.S.) $88.19 / (U.S.) $88.37
  • YTD % change-11.47%
  • Volume164,501
  • Average volume (10-day)1,210,740
  • Average volume (1-month)1,124,488
  • Average volume (3-month)1,191,573
  • 52-week range(U.S.) $80.01 to (U.S.) $141.58
  • Beta0.92
  • Trailing P/E28.07×
  • P/E 1 year forward39.36×
  • Forward PEG0.33×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.14
Updated September 4 10:24 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+33.96%

Based on its net profit margin of 33.96%, Medivation Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.78%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue176129275200
Total other revenue--------
Total revenue176129275200
Gross profit--------
Total cost of revenue--------
Total operating expense130129131109
Selling / general / administrative75847363
Research & development47455845
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)8------
Other operating expenses, total--------
Operating income46114392
Interest income (expense), net non-operating-5-6-6-6
Gain (loss) on sale of assets--------
Other--------
Income before tax40-513886
Income after tax26-316478
Income tax, total15-2-268
Net income26-316478
Total adjustments to net income--------
Net income before extra. items26-316478
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items26-316478
Inc. avail. to common incl. extra. items26-316478
Diluted net income26-316478
Dilution adjustment0--00
Diluted weighted average shares84788681
Diluted EPS excluding extraordinary itemsvalue per share0.31-0.041.910.96
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.37-0.041.910.96